 |
|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
|
|
|
|
* Residue conservation analysis
|
|
|
|
 |
|
|
 |
 |
 |
 |
Enzyme class:
|
 |
E.C.3.2.1.14
- Chitinase.
|
|
 |
 |
 |
 |
 |
Reaction:
|
 |
Hydrolysis of the 1,4-beta-linkages of N-acetyl-D-glucosamine polymers of chitin.
|
 |
 |
 |
 |
 |
 |
 |
|
 |
|
 |
|
|
Gene Ontology (GO) functional annotation
|
|
|
|
 |
 |
 |
|
 |
 |
 |
 |
|
 |
|
Biological process
|
carbohydrate metabolic process
|
2 terms
|
 |
|
Biochemical function
|
catalytic activity
|
4 terms
|
 |
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
DOI no:
|
J Biol Chem
278:20110-20116
(2003)
|
|
PubMed id:
|
|
|
|
|
| |
|
Crystal structures of allosamidin derivatives in complex with human macrophage chitinase.
|
|
F.V.Rao,
D.R.Houston,
R.G.Boot,
J.M.Aerts,
S.Sakuda,
D.M.van Aalten.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
The pseudotrisaccharide allosamidin is a potent family 18 chitinase inhibitor
with demonstrated biological activity against insects, fungi, and the Plasmodium
falciparum life cycle. The synthesis and biological properties of several
derivatives have been reported. The structural interactions of allosamidin with
several family 18 chitinases have been determined by x-ray crystallography
previously. Here, a high resolution structure of chitotriosidase, the human
macrophage chitinase, in complex with allosamidin is presented. In addition,
complexes of the allosamidin derivatives demethylallosamidin, methylallosamidin,
and glucoallosamidin B are described, together with their inhibitory properties.
Similar to other chitinases, inhibition of the human chitinase by allosamidin
derivatives lacking a methyl group is 10-fold stronger, and smaller effects are
observed for the methyl and C3 epimer derivatives. The structures explain the
effects on inhibition in terms of altered hydrogen bonding and hydrophobic
interactions, together with displaced water molecules. The data reported here
represent a first step toward structure-based design of specific allosamidin
derivatives.
|
|
|
|
|
| |
Selected figure(s)
|
|
|
| |
 |
 |
|
 |
|
 |
Figure 3.
FIG. 3. Complexes with allosamidin derivatives. Stereo
images of the final structures of the human chitinase in complex
with allosamidin and its derivatives are shown. Side chains
interacting with the allosamidins (also indicated in Fig. 2) are
shown in a sticks representation. The allosamidins are shown as
a sticks model with orange carbons. Water molecules involved in
allosamidin hydrogen bonds are shown as red spheres. Hydrogen
bonds are shown as dotted green lines and are listed in Table
IV. The unbiased F[o] - F[c], [calc] maps before
inclusion of models for the inhibitors in the refinement are
shown in magenta, contoured at 2.25 .
|
 |
Figure 4.
FIG. 4. Sequence conservation in the active site. Stereo
image of the molecular surfaces calculated from HCHT in the
HCHT·ALLO complex and hevamine in the
hevamine·ALLO complex (18) is shown. Blue surface
corresponds to conserved residues (Fig. 2), which are also shown
as a sticks model. ALLO is shown as a sticks model with green
carbons. The / domain, absent in
hevamine, is indicated in HCHT.
|
 |
|
|
|
| |
The above figures are
reprinted
by permission from the ASBMB:
J Biol Chem
(2003,
278,
20110-20116)
copyright 2003.
|
|
| |
Figures were
selected
by an automated process.
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Literature references that cite this PDB file's key reference
|
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
A.W.Schüttelkopf,
L.Gros,
D.E.Blair,
J.A.Frearson,
D.M.van Aalten,
and
I.H.Gilbert
(2010).
Acetazolamide-based fungal chitinase inhibitors.
|
| |
Bioorg Med Chem, 18,
8334-8340.
|
 |
|
|
|
|
 |
H.Li,
and
L.H.Greene
(2010).
Sequence and structural analysis of the chitinase insertion domain reveals two conserved motifs involved in chitin-binding.
|
| |
PLoS One, 5,
e8654.
|
 |
|
|
|
|
 |
A.M.Olland,
J.Strand,
E.Presman,
R.Czerwinski,
D.Joseph-McCarthy,
R.Krykbaev,
G.Schlingmann,
R.Chopra,
L.Lin,
M.Fleming,
R.Kriz,
M.Stahl,
W.Somers,
L.Fitz,
and
L.Mosyak
(2009).
Triad of polar residues implicated in pH specificity of acidic mammalian chitinase.
|
| |
Protein Sci, 18,
569-578.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
A.P.Bussink,
M.Verhoek,
J.Vreede,
K.Ghauharali-van der Vlugt,
W.E.Donker-Koopman,
R.R.Sprenger,
C.E.Hollak,
J.M.Aerts,
and
R.G.Boot
(2009).
Common G102S polymorphism in chitotriosidase differentially affects activity towards 4-methylumbelliferyl substrates.
|
| |
FEBS J, 276,
5678-5688.
|
 |
|
|
|
|
 |
R.G.Boot,
M.J.van Breemen,
W.Wegdam,
R.R.Sprenger,
S.de Jong,
D.Speijer,
C.E.Hollak,
L.van Dussen,
H.C.Hoefsloot,
A.K.Smilde,
C.G.de Koster,
J.P.Vissers,
and
J.M.Aerts
(2009).
Gaucher disease: a model disorder for biomarker discovery.
|
| |
Expert Rev Proteomics, 6,
411-419.
|
 |
|
|
|
|
 |
Y.Lü,
H.Yang,
H.Hu,
Y.Wang,
Z.Rao,
and
C.Jin
(2009).
Mutation of Trp137 to glutamate completely removes transglycosyl activity associated with the Aspergillus fumigatus AfChiB1.
|
| |
Glycoconj J, 26,
525-534.
|
 |
|
|
|
|
 |
Y.S.Zhao,
Q.C.Zheng,
H.X.Zhang,
H.Y.Chu,
and
C.C.Sun
(2009).
Analysis of a three-dimensional structure of human acidic mammalian chitinase obtained by homology modeling and ligand binding studies.
|
| |
J Mol Model, 15,
499-505.
|
 |
|
|
|
|
 |
C.Petter,
C.Scholz,
H.Wessner,
G.Hansen,
P.Henklein,
T.Watanabe,
and
W.Höhne
(2008).
Phage display screening for peptidic chitinase inhibitors.
|
| |
J Mol Recognit, 21,
401-409.
|
 |
|
|
|
|
 |
R.Hurtado-Guerrero,
and
D.M.van Aalten
(2007).
Structure of Saccharomyces cerevisiae chitinase 1 and screening-based discovery of potent inhibitors.
|
| |
Chem Biol, 14,
589-599.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
F.H.Cederkvist,
A.D.Zamfir,
S.Bahrke,
V.G.Eijsink,
M.Sørlie,
J.Peter-Katalinić,
and
M.G.Peter
(2006).
Identification of a high-affinity-binding oligosaccharide by (+) nanoelectrospray quadrupole time-of-flight tandem mass spectrometry of a noncovalent enzyme-ligand complex.
|
| |
Angew Chem Int Ed Engl, 45,
2429-2434.
|
 |
|
|
|
|
 |
J.M.Aerts,
C.E.Hollak,
R.G.Boot,
J.E.Groener,
and
M.Maas
(2006).
Substrate reduction therapy of glycosphingolipid storage disorders.
|
| |
J Inherit Metab Dis, 29,
449-456.
|
 |
|
|
|
|
 |
F.V.Rao,
O.A.Andersen,
K.A.Vora,
J.A.Demartino,
and
D.M.van Aalten
(2005).
Methylxanthine drugs are chitinase inhibitors: investigation of inhibition and binding modes.
|
| |
Chem Biol, 12,
973-980.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
O.A.Andersen,
M.J.Dixon,
I.M.Eggleston,
and
D.M.van Aalten
(2005).
Natural product family 18 chitinase inhibitors.
|
| |
Nat Prod Rep, 22,
563-579.
|
 |
|
|
|
|
 |
A.W.Schüttelkopf,
and
D.M.van Aalten
(2004).
PRODRG: a tool for high-throughput crystallography of protein-ligand complexes.
|
| |
Acta Crystallogr D Biol Crystallogr, 60,
1355-1363.
|
 |
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
Where a reference describes a PDB structure, the PDB
codes are
shown on the right.
|
|